We are live on ! Find out more
BGMS

Bio Green Med Solution Inc

3 hedge funds and large institutions have $2.79M invested in Bio Green Med Solution Inc in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% less ownership

Funds ownership: 0%0% (-0%)

16% less capital invested

Capital invested by funds: $3.33M → $2.79M (-$537K)

25% less funds holding

Funds holding: 43 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.07%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
Increased
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change

BGMS Hedge Fund Activity: Q2 2017 in Review

3 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc (BGMS) for Q2 2017, worth a combined $2.79M — down 16% from $3.33M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of BGMS and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.

The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $361K sold.

  • 3 institutional investors held Bio Green Med Solution Inc (BGMS) as of Q2 2017, down from 4 in Q1 2017.
  • Funds reported $2.79M of Bio Green Med Solution Inc stock for Q2 2017, down 16% quarter-over-quarter.
  • 0 funds opened new Bio Green Med Solution Inc positions in Q2 2017 and 1 closed out, a net change of -1 holder.
  • The largest Bio Green Med Solution Inc seller in Q2 2017 was Dimensional Fund Advisors, an estimated $361K sold.

Based on aggregated 13F filings for Q2 2017.